← All Syra Health CORP filings

Syra Health CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OQB
SYRA
Syra Health CORP
Form 4: Syra Health CEO Receives Stock Grant
Gregory R. Alexander, CEO of Syra Health Corp, received 368,458 shares of common stock on August 11, 2026.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Director Acquires Stock Options
Syra Health Corp. Director Vijayapal Reddy acquired 43,348 stock options with a $0.07 exercise price, vesting over three years.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Director Ketan Paranjape Boosts Equity
Syra Health Corp. Director Ketan Paranjape acquired 43,348 stock options with a $0.07 exercise price, vesting over three years.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Director Avutu Reddy Acquires Stock Options
Syra Health Corp. Director Avutu Reddy acquired 43,348 stock options with a $0.07 exercise price, vesting over three years.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Andrew Dahlem Acquires Stock Options
Director Andrew Dahlem of Syra Health Corp acquired 9,102 stock options on January 7, 2025, as part of the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
A Syra Health Corp director, Vijayapal Reddy, acquired 12,136 stock options on January 7, 2025, under the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
A Syra Health Corp director, Sherron Rogers, acquired 9,102 stock options at an exercise price of $0.7386 on January 7, 2025.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
A Syra Health Corp director, Avutu Reddy, acquired 12,136 stock options on January 7, 2025, under the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Ketan Paranjape Reports Stock Option Grant
Director Ketan Paranjape of Syra Health Corp. reported the acquisition of 15,170 stock options on January 7, 2025.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
A Syra Health Corp director, Sherron Rogers, acquired 11,581 stock options on November 14, 2024, under the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
A Syra Health Corp director, Vijayapal Reddy, acquired 15,442 stock options at an exercise price of $0.3683 on November 14, 2024.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Ketan Paranjape Acquires Stock Options
Director Ketan Paranjape of Syra Health Corp acquired 19,303 stock options on November 14, 2024, under the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
A Syra Health Corp director, Avutu Reddy, acquired 15,442 stock options on November 14, 2024, under the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp Director Acquires Stock Options
Andrew Dahlem, a director at Syra Health Corp, acquired 11,581 stock options on November 14, 2024, under the company's 2022 Omnibus Equity Incentive Plan.
OQB
SYRA
Syra Health CORP
Form 4: Syra Health Corp CFO Priya Prasad Reports Multiple Transactions in Company Stock
CFO and COO of Syra Health Corp, Priya Prasad, reports a series of acquisitions and disposals of Class A Common Stock and related warrants, including covering profits from short-swing transactions.